Galactica Biotech

The AI engine Fit Assessment

Beta

Galactica Biotech effectively leverages machine learning and advanced analytical methods to discover new therapeutic applications for existing drugs, fulfilling all specified requirements.

Blurb

Galactica Biotech develops a cutting edge proprietary machine learning method that is able to identify new applications for molecules.

HQ Location

Ireland

Founded

2014

Employees

1 - 10

Total funding raised

Not available

Last Funding Event

Seed, June 7, 2017

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Drug Discovery Optimization
  • Drug Repurposing

Operator of a drug development platform intended to set new standards in the pharmaceutical industry adding value to drugs. The company's system utilizes advanced analytical methods including AI and ML to identify new uses for molecules and provides a drug-repurposing method to identify novel applications for molecules in the market and in the development of major and orphan diseases, enabling patients to reduce risk and companies to save time and cost.